| Ralph M Baker, PHD | |
|
215 W, Bridge St., Ste 5, Yerington, NV 89447-2544 | |
| (775) 463-3191 | |
| (775) 463-4641 |
| Full Name | Ralph M Baker |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 215 W, Bridge St., Yerington, Nevada |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083775209 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PY0359 (Nevada) | Primary |
| Entity Name | State Of Nevada |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760572010 PECOS PAC ID: 9234022153 Enrollment ID: O20040212000160 |
News Archive
The University of Leicester will celebrate the achievements of leaders and pioneers in their fields by conferring them with honorary degrees at ceremonies this week (14-17 July).
"Near-poor" Americans-;people just above the federal poverty level but still well below the average U.S. income-;who rely on Medicare for health insurance face high medical bills and may forgo essential health care, according to new research led by health policy scientists at the University of Pittsburgh Graduate School of Public Health.
A new North American survey of 500+ clinical research site professionals documents the impact of more kinds of, and more complex, clinical trials. The survey focused on 3-year trial trends and found key challenges in subject recruitment/retention and tracking and reporting data.
Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one that use of Avastin® (bevacizumab) in combination with paclitaxel for previously untreated (first-line) advanced HER2-negative breast cancer be removed from Avastin's U.S. label.
Meda Pharmaceuticals Inc. today announced the launch of Onsolis(TM)(fentanyl buccal soluble film) in the U.S. for the management of breakthrough pain (BTP) in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ralph M Baker, PHD 727 Fairview Dr., Ste A, Carson City, NV 89701-5493 Ph: (775) 684-5000 | Ralph M Baker, PHD 215 W, Bridge St., Ste 5, Yerington, NV 89447-2544 Ph: (775) 463-3191 |
News Archive
The University of Leicester will celebrate the achievements of leaders and pioneers in their fields by conferring them with honorary degrees at ceremonies this week (14-17 July).
"Near-poor" Americans-;people just above the federal poverty level but still well below the average U.S. income-;who rely on Medicare for health insurance face high medical bills and may forgo essential health care, according to new research led by health policy scientists at the University of Pittsburgh Graduate School of Public Health.
A new North American survey of 500+ clinical research site professionals documents the impact of more kinds of, and more complex, clinical trials. The survey focused on 3-year trial trends and found key challenges in subject recruitment/retention and tracking and reporting data.
Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one that use of Avastin® (bevacizumab) in combination with paclitaxel for previously untreated (first-line) advanced HER2-negative breast cancer be removed from Avastin's U.S. label.
Meda Pharmaceuticals Inc. today announced the launch of Onsolis(TM)(fentanyl buccal soluble film) in the U.S. for the management of breakthrough pain (BTP) in patients with cancer, eighteen years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.
› Verified 2 days ago